Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06334471

Whole Genome Sequencing in Breast Cancer

Sponsor: Inocras Korea Inc.

View on ClinicalTrials.gov

Summary

This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish new treatment guidelines aligned with the paradigm shift in precision medicine. The study will include both prospective and retrospective cohorts totaling 1200 participants. Prospective participants must provide consent and be eligible for tissue collection, while retrospective participants must have histologically confirmed breast cancer and available tissue samples from Samsung Medical Center Biobank. The study period spans 3 years for subject enrollment and 5 years for follow-up observations, with an expected completion date of December 31, 2030.

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1200

Start Date

2022-08-02

Completion Date

2030-12-31

Last Updated

2024-04-03

Healthy Volunteers

Not specified

Conditions

Interventions

OTHER

no intervention needed

no intervention needed

Locations (1)

Samsung Medical Center

Seoul, South Korea